PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.24%
Negative 10Y revenue/share CAGR while EXP stands at 263.77%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-3.41%
Negative 5Y CAGR while EXP stands at 122.56%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
33.22%
3Y revenue/share CAGR under 50% of EXP's 70.47%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
26.97%
10Y OCF/share CAGR under 50% of EXP's 245.05%. Michael Burry would worry about a persistent underperformance in cash creation.
10.06%
Below 50% of EXP's 49.96%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-25.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
518.86%
Net income/share CAGR 1.25-1.5x EXP's 393.95%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
18.05%
Below 50% of EXP's 180.19%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
197.03%
3Y net income/share CAGR above 1.5x EXP's 43.38%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
120.25%
10Y equity/share CAGR in line with EXP's 128.04%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
50.93%
5Y equity/share CAGR 1.25-1.5x EXP's 43.80%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
15.48%
3Y equity/share CAGR at 75-90% of EXP's 18.21%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-100.00%
Cut dividends over 10 years while EXP stands at 149.61%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while EXP stands at 146.85%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while EXP invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
15.06%
AR growth well above EXP's 8.68%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.72%
Inventory shrinking or stable vs. EXP's 12.01%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
5.72%
Asset growth above 1.5x EXP's 3.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.72%
Positive BV/share change while EXP is negative. John Neff sees a clear edge over a competitor losing equity.
7.11%
Debt growth far above EXP's 5.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.